Kalika Farmer

Managing Partner at Delphi

📍 New York City Metropolitan Area, United States🔄 Updated September 2026💼 14 investments📅 8 years investing🗓 Last invested Jul 2025
VC🌍 United States
14
Total investments
7
Early stage
4
Mid stage
1
Late stage
8y
Years active

Portfolio

14 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jul 2025
Making extinction a thing of the past. Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction. Colossal is accepting humanity’s duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through cutting-edge science and technologies.
Investor
Mar 2024
Cambrian Bio is a clinical-stage drug development company building the medicines that will modernize healthcare in the 21st century. Our focus lies in creating innovative therapeutics designed to treat and ultimately prevent some of todays most debilitating chronic diseases, including platforms targeting the critical metabolic pathways that decline with age such as AMPK activation, mitochondrial function, and mTORC1 inhibition, to extend the period of life spent in good health.
Board Observer
Mar 2023
Our Rose Delights are a single-strain house-made rosin and fresh fruit Turkish Delight-style infused edible in seasonal flavors. Flavors include Rose Hibiscus, Alphonso Mango (offered in an array of single-strain flower rosins), and seasonally changing recipes celebrating collaborations with chefs, artists, and producers whose work inspires our brand.
late stageConsumer Goods
Investor
Dec 2021
Transcend Therapeutics, founded in 2021, is a clinical-stage, neuroscience-focused company developing rapid-acting treatments for neuropsychiatric diseases. Our mission is to develop new drugs for the millions of people for whom current psychiatric medicines have not worked. Our leadership team has made pivotal contributions to 13 FDA approvals (including recent MDD approval), $3.5B in M&A, and significant public company value creation. As a Public Benefit Corporation, we have pledged 10% of founding shares toward nonprofits focused on scientific research and access.
Investor
Aug 2021
Beckley Psytech is now AtaiBeckley, a global leader in transformative mental health therapies, following the successful strategic combination with atai Life Sciences. To stay up to date with all the latest news, please follow @AtaiBeckley and visit our website at www.ataibeckley.com.
Investor
Jul 2021
Journey Colab is unlocking the science of psychedelics to build a new model of addiction care combining the potential of neuroplasticity-promoting therapeutics with psychotherapy and community support. Our lead compound is synthetic Mescaline HCl for patients with alcohol use disorder (AUD), who are in desperate need of durable remission from this chronic, relapsing condition. Through our unique stakeholder structure, we have built an experienced team dedicated to our mission of creating scientifically rigorous and clinically validated treatments and improving equitable access to care.
Investor
Mar 2021
Zuzu is a new kind of alcohol company started by two women who are tired of wine hangovers, tired canned coolers and spiked seltzers that taste synthetic and tired of the absence of clear nutritional information in alcohol. We have a background in the local and sustainable food world and we bring a set of deeply held beliefs about high quality ingredients to everything we do.
Investor
Jan 2021
Mindbloom offers guided at-home ketamine therapy to transform your mental health. Together with medical leaders in the field, we have created a best-in-class treatment program that is driving transformational outcomes for our clients. It’s a new day for mental health, and the future looks bright. We have an award-winning company, culture, and leadership team: * Top 150 Digital Health Startups — CB Insights * 50 Best Remote-First Companies to Work For in 2021 — BuiltIn * Top 25 Consumer Healthcare Executives in 2020 — The Healthcare Technology Report *2022 Tony Hsieh Award for most transformational cultures *22 Remote Startups to Watch in 2022 *29 Telemedicine Companies to Know Were backed by Tier 1 VCs, and were on a mission to transform lives to transform the world. Join us! **Spam alert** It’s been brought to our attention that a spam account has been emailing Mindbloom applicants asking that an app be downloaded to apply for open Mindbloom positions. These messages are currently being sent from support@mindbloom.site. Please note that our team will not ask anyone to download an app. All correspondence from the Mindbloom team will come directly from a mindbloom.com email address. We apologize for any confusion. Stay safe!
Investor
Jun 2020
We’re a state-of-the-art medical practice with a root-cause, whole person approach and a focus on genuine doctor-patient relationships, data, and technology. Join the journey today - were hiring! Check out open roles at https://www.parsleyhealth.com/careers/
Investor
Feb 2019
The #1 global leader in expert content for Health, Wellness, Workplace, Travel, and Education — helping 1,000+ companies. JOIN THOUSANDS OF COMPANIES Caravan has a solution for every company. We help organizations, influencers, and leaders all around the world, to increase the power of their brand, create impact opportunities, engage new audiences, and develop healthier and happier communities. Caravan is featured on the New York Times, ELLE, Yahoo, and PureWow. THE WORLDS BEST EXPERT CONTENT * Premium Production * Guided by Top Experts * Optimized for Engagement * Trusted & Tested Content * Backed by Science, Accuracy Ensured * Compliant with All Regulatory Needs TRUSTED & TESTED CONTENT * 100+ Top Certified Teachers & Experts * 2,000+ High Quality Videos & Audios * 100+ Powerful Programs * Culturally Relevant, in 15+ Languages * 1,000+ Expert Written Articles, Illustrations, And More ALL-IN-ONE SOLUTION *Medical Education *Workplace Wellness *Mental Health *Physical Health *Financial Wellness *Mindful Nutrition And so many more... We envision a world where everyone can access all the best health, fitness, and wellness practices, techniques and rituals – no matter your age, income, or location. Contact us at info@caravanwellness.com
Investor
Nov 2018
Good Money is building modern financial products that help people achieve financial freedom, while doing good for the planet. We're a passionate team of engineers, designers, business builders, and entrepreneurs - on a mission to make money do good. If you're looking to join an all-star team that's building at the bleeding edge of a once-in-a-generation opportunity to invent the future of consumer financial services, look no further - we're hiring! *** Good Money's co-founders have a track record of scaling high-growth companies in the D2C, Consumer Software, and B2B/SaaS verticals that have generated $1.5B+ in revenue and scaled to tens of millions of users. To date, Good Money has raised $30M+ in funding from top fintech and impact investors including Galaxy Digital, Blocktower Capital, Blockchange, Boost, Breyer Capital, Cervin Ventures, CUNA Mutual, Designer Fund, M13, Morgan Creek Digital, MS&AD Ventures, SVB, Uprising VC, and WTI.
Investor
Jul 2018
Our Product: Datavore is an adaptive data analytics platform that allows you to quickly explore your datasets and ask meaningful questions. Our intuitive interface enables you to easily create repeatable workflows for data aggregation, normalization, analysis, and visualization. Our Team: The Datavore team has deep domain expertise in databases, time series, and analytics with a successful track record of building technology within the financial services sector. The team has experience working at companies including Goldman Sachs, Citigroup, UBS, Thomson Reuters, Ernst & Young, and KPMG.
Investor
May 2018
Smallhold is on a mission to dramatically shorten the distance between you and fresh, gourmet mushrooms. Our growing network of organic farms is upending the traditional farming model with patented technology and a sophisticated supply chain, dramatically increasing access to freshly harvested mushrooms. You can find Smallhold in places like Whole Foods, Central Market, FreshDirect, farmers markets, and more. You can watch our mushrooms grow in tech-enabled minifarms inside restaurants, grocery stores, and nonprofits, or even on your own kitchen counter with one of our home grow kits, available at smallhold.com.
early stageFarming
Investor
Jan 2018
Imperfect Foods was founded in 2015 with a mission to reduce food waste and build a better food system for everyone. We offer imperfect (yet delicious) produce, affordable pantry items, and quality meat and dairy. We deliver them conveniently to our customers’ doorsteps and pride ourselves on offering up to a 30% discount compared to grocery store prices. Our customers can get the healthy, seasonal produce they want alongside the grocery staples they rely on, without having to compromise their budget or values. We’re proving that doing the right thing for the planet doesn’t have to cost more, and that shopping for quality ingredients can support the people and resources that it takes to grow our favorite foods. Were headquartered in San Francisco with operations all over the country. Check our website to see if there is an Imperfect near you! Were looking for folks who are positive, motivated, and ready to change the world. If that sounds like you, drop us a line!
Experience · 17 entries
All (17)
Investments (14)
Board (1)
2025
Investor
Jul 2025
Making extinction a thing of the past. Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction. Colossal is accepting humanity’s duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through cutting-edge science and technologies.
2024
Investor
Mar 2024
Cambrian Bio is a clinical-stage drug development company building the medicines that will modernize healthcare in the 21st century. Our focus lies in creating innovative therapeutics designed to treat and ultimately prevent some of todays most debilitating chronic diseases, including platforms targeting the critical metabolic pathways that decline with age such as AMPK activation, mitochondrial function, and mTORC1 inhibition, to extend the period of life spent in good health.
2023
Board Observer
Mar 2023
Our Rose Delights are a single-strain house-made rosin and fresh fruit Turkish Delight-style infused edible in seasonal flavors. Flavors include Rose Hibiscus, Alphonso Mango (offered in an array of single-strain flower rosins), and seasonally changing recipes celebrating collaborations with chefs, artists, and producers whose work inspires our brand.
late stageConsumer Goods
2021
Investor
Dec 2021
Transcend Therapeutics, founded in 2021, is a clinical-stage, neuroscience-focused company developing rapid-acting treatments for neuropsychiatric diseases. Our mission is to develop new drugs for the millions of people for whom current psychiatric medicines have not worked. Our leadership team has made pivotal contributions to 13 FDA approvals (including recent MDD approval), $3.5B in M&A, and significant public company value creation. As a Public Benefit Corporation, we have pledged 10% of founding shares toward nonprofits focused on scientific research and access.
Investor
Aug 2021
Beckley Psytech is now AtaiBeckley, a global leader in transformative mental health therapies, following the successful strategic combination with atai Life Sciences. To stay up to date with all the latest news, please follow @AtaiBeckley and visit our website at www.ataibeckley.com.
Show all 17 entries ↓
Investment activity
2018–2025 · 14 investments
20184201912020120215202312024120251
Recent (last 2 years)Earlier